The global phosphodiesterase (PDE) inhibitors market is forecasted to grow at a CAGR of 6.90% from 2025 to 2034. With the rising global prevalence of erectile dysfunction and increasing adoption of targeted therapies like PDE5 inhibitors, the market is witnessing significant momentum in both research and treatment availability. https://www.expertmarketresearch.com/reports/phosphodiesterase-inhibitors-market